First Tracks Biotherapeutics Inc. (B43)
Market Closed
XDUS 
NASDAQ (NGS) Primary XDUS €
€
- Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
€
Previous Close Want to track B43 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
B43 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
B43 Chart
First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long
First Tracks Biotherapeutics, spun off from AnaptysBio, launches with $180M cash and a diverse, early-stage pipeline. I rate TRAX as a Hold due to post-spin instability, near-term dilution risk, and a multi-year path to revenue. ANB033 targets celiac disease, with no current FDA-approved therapies; pivotal trial data are expected in Q4 2026–2027, with commercialization likely a decade away.
Seekingalpha | 1 month ago
First Tracks Biotherapeutics Inc. (B43) FAQ
What is the stock price today?
The current price is €0.00.
On which exchange is it traded?
First Tracks Biotherapeutics Inc. is listed on XDUS.
What is its stock symbol?
The ticker symbol is B43.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has First Tracks Biotherapeutics Inc. ever had a stock split?
No, there has never been a stock split.
First Tracks Biotherapeutics Inc. Profile
| Biotechnology Industry | Healthcare Sector | Daniel R. Faga CEO | XDUS Exchange | US3371851029 ISIN |
| US Country | 104 Employees | - Last Dividend | - Last Split | - IPO Date |
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Contact Information
Address: 10770 Wateridge Circle
Phone: 858 362 6295
Website: https://www.firsttracksbio.com
